CRM Cancer Research Results
CRM, Calorie restriction mimetics (CRMs): Click to Expand ⟱
| Source: |
| Type: |
Calorie restriction mimetics (CRMs) are compounds that appear to mimic some of the biochemical effects of caloric restriction without the need to actually reduce caloric intake.
-Resveratrol:Known for activating sirtuins (e.g., SIRT1)
-Curcumin
-Quercetin
-EGCG
-Spermidine
-Fisetin
-Berberine
-Pterostilbene
-Hydroxytyrosol
-Sulforaphane
-Cinnamaldehyde
-Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN)
-Alpha-Ketoglutarate (AKG)
-Rapamycin (Sirolimus
|
Scientific Papers found: Click to Expand⟱
*CRM↑, *HATs↓, *NF-kB↓, *EP300↓,
*antiOx↑, *ROS∅, *CRM↑,
*CRM↑, *neuroP↑, *AChE↓,
*OS↑, *AntiAge↑, *cardioP↑, *neuroP↑, AntiCan↑, *TNF-α↓, *Weight↓, *BP↓, *Inflam↓, *Insulin↓, *ROS↓, *AMPK↑, *mTOR↓, *SIRT1↑, CRM↑,
CRM↑, ChemoSen↑, RadioS↑, eff↑, eff↑, IGF-1↓, TumCG↓, AMPK↑, eff↑, ChemoSen↑, RadioS↑, ROS↑, DNAdam↑, eff↑, HO-1↓,
CRM↑, ACLY↓, TumAuto↑, Inflam↓, TumCG↓, toxicity∅, lipoGen↓, *ROS↓, *OCR↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↑, *ROS↓, *SOD↑, *Catalase↑, *GSH↑, *GSTs↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *iNOS↓, *NO↓, *TAC↑, *NOX4↓, *Inflam↓, *IL1↓, *IL6↓, *IL8↓, *IL1β↓, *TNF-α↓, *TLR2↓, *TLR4↓, *VCAM-1↓, *ICAM-1↓, *STAT3↓, *NF-kB↓, *ERK↓, *BP↓, ROS↓, PGE2↓, cardioP↑, *neuroP↑, *creat↓, *RenoP↑, *CRM↑,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
*CRM↑, *OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↓, *ROS↑, *SOD↑, *GSH↑, *NRF2↑, *MDA↓, *HNE↓, *Inflam↓, *MAPK↓, *IL6↓, *TNF-α↓, *HO-1↑, *cardioP↑, *neuroP↑, *CRM↑, *NLRP3↓,
*AntiAge↑, *IGF-1↓, *AMPK↑, *CRM↑, *PGC-1α↑, *mtDam↓, *motorD↑, *hepatoP↑, *Dose↝,
*AMPK↑, *SIRT1↑, *PGC-1α↑, *BP↓, *CRM↑, *Dose↝, *mtDam↓, *ALAT↓, *hepatoP↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
TumAuto↑, Apoptosis↑, OS↑, CRM↑, TumCG⇅, cardioP↑, cognitive↑, *Dose⇅,
*EP300↓, *mTORC1↓, *CRM↑, *HATs↓, *p62↓, *AntiAge↑, AntiCan↑,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↓, 1, ROS↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACLY↓, 1, AMPK↑, 1, CRM↑, 4, lipoGen↓, 1,
Cell Death ⓘ
Apoptosis↑, 2, Casp↑, 1, p27↓, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
IGF-1↓, 1, mTOR↓, 1, TumCG↓, 2, TumCG⇅, 1,
Migration ⓘ
TumCP↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, PGE2↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3, eff↑, 4, RadioS↑, 2,
Functional Outcomes ⓘ
AntiCan↑, 3, cardioP↑, 2, cognitive↑, 1, OS↑, 1, Risk↓, 2, toxicity∅, 1,
Total Targets: 32
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 2, Catalase↑, 1, GSH↑, 2, GSTs↑, 1, HNE↓, 1, HO-1↑, 2, lipid-P↓, 1, MDA↓, 2, NOX4↓, 1, NQO1↑, 1, NRF2↑, 3, ROS↓, 5, ROS↑, 1, ROS∅, 1, SOD↑, 2, SOD2↑, 1, TAC↑, 2, TrxR1↑, 1,
Mitochondria & Bioenergetics ⓘ
Insulin↓, 2, mtDam↓, 2, OCR↓, 1, PGC-1α↑, 2,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 2, AMPK↑, 5, CRM↑, 11, glucose↓, 1, glyC↓, 1, LDL↓, 1, SIRT1↑, 2,
Cell Death ⓘ
iNOS↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
HATs↓, 2,
Protein Folding & ER Stress ⓘ
NQO2↑, 1,
Autophagy & Lysosomes ⓘ
p62↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EP300↓, 2, ERK↓, 1, IGF-1↓, 1, mTOR↓, 1, mTORC1↓, 1, STAT3↓, 1,
Migration ⓘ
VCAM-1↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Immune & Inflammatory Signaling ⓘ
ICAM-1↓, 1, IL1↓, 1, IL1β↓, 1, IL6↓, 2, IL8↓, 1, Inflam↓, 4, NF-kB↓, 2, TLR2↓, 1, TLR4↓, 1, TNF-α↓, 3,
Synaptic & Neurotransmission ⓘ
AChE↓, 1,
Protein Aggregation ⓘ
AGEs↓, 1, NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, Dose⇅, 1, Dose↝, 2, Half-Life↝, 1,
Clinical Biomarkers ⓘ
ALAT↓, 2, BP↓, 3, creat↓, 1, IL6↓, 2,
Functional Outcomes ⓘ
AntiAge↑, 4, AntiDiabetic↑, 2, cardioP↑, 4, hepatoP↑, 3, motorD↑, 1, neuroP↑, 5, OS↑, 2, RenoP↑, 1, Strength↑, 1, toxicity⇅, 1, toxicity↝, 1, Weight↓, 1,
Total Targets: 76
Scientific Paper Hit Count for: CRM, Calorie restriction mimetics (CRMs)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1128 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page